Session I: ALL

Moderator(s)

• 

  Gail Roboz, MD

  Weill Cornell Medicine, NewYork Presbyterian Hospital
  New York, New York, United States

Presenter(s)

• 

  Michal Bar-Natan, MD

  Weill Cornell Medicine
  New York, New York, United States
• 

  Elias Jabbour, MD

  MD Anderson Cancer Center, The University of Texas
  Houston, Texas, United States
• 

  Wendy Stock, MD, MA

  University of Chicago
  Chicago, Illinois, United States

Presentations:

• 9:00 AM – 9:05 AM ET

  Welcome and Introduction: Acute Leukemia & Myeloproliferative/Myelodysplastic Diseases Session
  

  Chair: Morton Coleman, MD – Weill Cornell Medicine

  Co-Chair: Gail J. Roboz, MD – Weill Cornell Medicine, NewYork Presbyterian Hospital
• 9:05 AM – 9:10 AM ET

  Session Welcome
• 9:10 AM – 9:30 AM ET

  Can We Eliminate Chemotherapy in Ph+ ALL?
  

  Speaker: Elias Jabbour, MD – MD Anderson Cancer Center, The University of Texas
• 9:30 AM – 9:50 AM ET

  When, How, and For Whom to Use Asparagine Depletion in ALL?
  

  Speaker: Michal Bar-Natan, MD – Weill Cornell Medicine
• 9:50 AM – 10:10 AM ET

  Updates in T cell ALL
  

  Speaker: Wendy Stock, MD, MA – University of Chicago
• 10:10 AM – 10:30 AM ET

  Panel Discussion
  

  Panelist: Michal Bar-Natan, MD – Weill Cornell Medicine

  Panelist: Elias Jabbour, MD – MD Anderson Cancer Center, The University of Texas

  Panelist: Wendy Stock, MD, MA – University of Chicago